Why Mispro: The Proven Partner for In Vivo Discovery
Trusted by 100+ biotech companies nationwide, Mispro delivers research-ready vivarium space and integrated services that provide the control and scientific rigor required to advance in vivo programs with speed and confidence.
Built for Rigor. Designed for Control. Positioned for Scale.
Mispro’s contract vivarium facilities and integrated services enable biotech and biopharma companies of all sizes, across therapeutic areas and modalities, to conduct, control, and scale preclinical in vivo rodent studies with precision and confidence.
-
AAALAC-accredited vivarium environments with integrated husbandry, veterinary, and IACUC oversight that supports data integrity, reproducibility, and regulatory diligence from first study through exit.
-
Decades of credentialed expertise in laboratory animal science and vivarium operations, ensuring ethical animal care and stable research environments that support downstream reproducibility.
-
Proximity-based national network across every major U.S. biotech hub placing studies minutes from labs, offices, universities, and investors, reducing friction and preserving speed as companies scale.
-
Venture-aligned program experience supporting hundreds of biotech companies across therapeutic areas and advanced modalities, strengthening scientific credibility, capital efficiency, and acquisition readiness.
Metrics That Matter
Built for companies advancing in vivo programs under real capital pressure, Mispro’s model converts operational control into measurable gains in throughput, cost efficiency, data reliability, and acquisition-level outcomes.
Mispro vs. CRO
- 6X Increase in study throughput
- 50% Less spend over time
- 70% Reduction in failure rates
Credentials & Scientific Leadership
- 80% Lab Animal Technicians professionally certified
- 100% Veterinary staff ACLAM certified
- 100+ Peer-Reviewed Publications across Operations & Compliance
Translational Capacity
- 60+ Areas of research supported
- 120+ Companies currently supported
- 500+ Scientists working in Mispro facilities
Exit Activity Across Mispro Vivaria
- 75% Of biotech M&A activity in 2025
- $19B In 2025 M&A value
- 25% Achieved exits since 2018
Client Testimonials
Compliant. Accredited. Recognized.
Meeting the highest standards in oversight, accreditation, and animal research excellence.
Are Contract Research Organizations Best for Preclinical Research? A Smarter Alternative.
Read Mispro Blog


